Please provide your email address to receive an email when new articles are posted on . Pancreatic cancer is among the deadliest malignancies, and those who specialize in its treatment eagerly embrace ...

SAN DIEGO--(BUSINESS WIRE)--Bluestar Genomics, an innovative company leading the development of next-generation liquid biopsy approaches to early cancer detection, today announced the presentation of ...

With pancreatic cancer being one of the deadliest cancers, the ability to catch lesions early could save lives, especially given the disease's high mortality rates. "Our work suggests that integrating ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist ...

SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the ...

Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...

For the vast majority of pancreatic cancer cases, the tumor grows undetected until it has already spread locally or to distant parts of the body. That means most patients, over 80% by some estimates, ...

Development of a National Cancer Registry in a Low Resourced Country: The Case of Kenya National Cancer Registry Programme Background: Pancreatic cancer is the fourth leading cause of cancer ...

Post-progression therapies and outcomes for patients with advanced, BRCA-related pancreatic cancer after receipt of PARP inhibitors: A national retrospective cohort study. This is an ASCO Meeting ...

My transplant team has a simultaneous pancreas-kidney transplant (SPKT) recipient who has a fistula in the pancreas allograft. He is 2 months post-SPKT, and it has been 1 month since he underwent 2 ...